首页> Muscle & nerve> Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).

Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).

导出 LinkOut

翻译打印收藏纠错

第一作者： Megan,Yerton

第一单位： Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

作者： Megan,Yerton ^[1] ; Allison,Winter ^[1] ; Dario,Gelevski ^[1] ; Grace,Addy ^[1] ; Anthony,Kostov ^[1] ; Cassandra,Lieberman ^[1] ; Harli,Weber ^[1] ; Michael,Doyle ^[1] ; Geli,Kane ^[1] ; Caroline,Cohen ^[1] ; Neil,Parikh ^[1] ; Katherine M,Burke ^[1] ; Margot,Rohrer ^[1] ; Taylor,Stirrat ^[1] ; Margaret,Bruno ^[1] ; Alison,Hochman ^[1] ; Sarah,Luppino ^[1] ; Jennifer,Scalia ^[1] ; Derek,D'Agostino ^[1] ; Ervin,Sinani ^[1] ; Hong,Yu ^[1] ; Kristin,Drake ^[1] ; Jennifer,Hagar ^[1] ; Alexander V,Sherman ^[1] ; Suma,Babu ^[1] ; James D,Berry ^[1] ; Merit E,Cudkowicz ^[1] ; Sabrina,Paganoni ^[2]

作者单位： Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. ^[1] Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.;Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA. ^[2]

关键词 amyotrophic lateral sclerosis expanded access investigational product motor neuron disease

医学主题词美国(United States);人类(Humans);肌萎缩侧索硬化(Amyotrophic Lateral Sclerosis);时间因素(Time Factors);美国食品和药物管理局(United States Food and Drug Administration)

DOI 10.1002/mus.27819

PMID 36929648

发布时间 2023-05-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交